FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

JOHN BENNETT

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Procedures

Physiology

Phagocytosis

Co-author Network

Publications

TOP 3
Yuichi Fukuda; Timothy G Myers; Huei-Fung Tsai; JOHN BENNETT
Transcriptional profiling of Candida glabrata during phagocytosis by neutrophils and in the infected mouse spleen.
Joanna Kubler-Kielb; Beata Maczynska; Weng-Ian Ng; Marzenna Bartoszewicz; JOHN BENNETT; Adam Junka; Evgeny Vinogradov; Adrian Zelazny; Rachel Schneerson
The capsular polysaccharide and lipopolysaccharide structures of two carbapenem resistant Klebsiella pneumoniae outbreak isolates.
Jason A Noble; Qin Su; Sara D Suffis; Huei-Fung Tsai; Timothy G Myers; JOHN BENNETT
STB5 is a negative regulator of azole resistance in Candida glabrata.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of JOHN BENNETT (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yuichi Fukuda; Timothy G Myers; Huei-Fung Tsai; JOHN BENNETT
Transcriptional profiling of Candida glabrata during phagocytosis by neutrophils and in the infected mouse spleen.
Infection and immunity 2013;81(4):1325-33.
2013: Joanna Kubler-Kielb; Beata Maczynska; Weng-Ian Ng; Marzenna Bartoszewicz; JOHN BENNETT; Adam Junka; Evgeny Vinogradov; Adrian Zelazny; Rachel Schneerson
The capsular polysaccharide and lipopolysaccharide structures of two carbapenem resistant Klebsiella pneumoniae outbreak isolates.
Carbohydrate research 2013;369():6-9.
2013: Jason A Noble; Qin Su; Sara D Suffis; Huei-Fung Tsai; Timothy G Myers; JOHN BENNETT
STB5 is a negative regulator of azole resistance in Candida glabrata.
Antimicrobial agents and chemotherapy 2013;57(2):959-67.
2012: Eric G Meissner; Yvonne Qvarnstrom; Maria Tsokos; JOHN BENNETT; Emily Y Chu; Alexandre da Silva; Juan Gea-Banacloche
Disseminated microsporidiosis in an immunosuppressed patient.
Emerging infectious diseases 2012;18(7):1155-8.
2012: Qingdi Quentin Li; Jeff Skinner; JOHN BENNETT
Evaluation of reference genes for real-time quantitative PCR studies in Candida glabrata following azole treatment.
BMC molecular biology 2012;13():22.
2012: JOHN BENNETT
Companion drugs for amphotericin B in cryptococcal meningitis: flucytosine, fluconazole, or...Nothing?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(1):129-30.
2011: Janyce A Sugui; Adrian M Zelazny; JOHN BENNETT; Jesica A Christensen; Kyung J Kwon-Chung
Hematogenously disseminated skin disease caused by Mucor velutinosus in a patient with acute myeloid leukemia.
Journal of clinical microbiology 2011;49(7):2728-32.
2011: Andrew H Limper; Kenneth S Knox; George A Sarosi; Neil M Ampel; JOHN BENNETT; Antonino Catanzaro; Scott F Davies; William E Dismukes; Chadi A Hage; Kieren Marr; Christopher H Mody; John R Perfect; David A Stevens
An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.
American journal of respiratory and critical care medicine 2011;183(1):96-128.
2010: Huei-Fung Tsai; Lindsay R Sammons; Xiaozhen Zhang; Sara D Suffis; Qin Su; Timothy G Myers; Kieren Marr; JOHN BENNETT
Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates.
Antimicrobial agents and chemotherapy 2010;54(8):3308-17.
2009: Tara N Palmore; Frida Stock; Margaret White; MaryAnn Bordner; Angela Michelin; JOHN BENNETT; Patrick R Murray; David K Henderson
A cluster of cases of nosocomial legionnaires disease linked to a contaminated hospital decorative water fountain.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2009;30(8):764-8.
2009: JOHN BENNETT
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008.
The Journal of antimicrobial chemotherapy 2009;63 Suppl 1():i23-6.
2008: Gregory P Bisson; Rudo Nthobatsong; Rameshwari Thakur; Gloria Lesetedi; Kavita Vinekar; Pablo Tebas; JOHN BENNETT; Stephen Gluckman; Tendani Gaolathe; Rob Roy MacGregor
The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana.
Journal of acquired immune deficiency syndromes (1999) 2008;49(2):227-9.
2008: Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack D Sobel; Claudio Viscoli; THOMAS WALSH; Johan Maertens; Thomas Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John Graybill; Lindsey R Baden; Peter G Pappas; JOHN BENNETT; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart Jan Kullberg; William E Dismukes; Ben E De Pauw
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(5):674-83.
2008: Dimitrios I Zonios; Judith Falloon; JOHN BENNETT; Pamela A Shaw; Doreen Chaitt; Michael W Baseler; Joseph W Adelsberger; Julia A Metcalf; Michael A Polis; Stephen J Kovacs; Joseph A Kovacs; Richard Davey; H Clifford Lane; Henry Masur; Irini Sereti
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.
Blood 2008;112(2):287-94.
2008: Dimitrios I Zonios; Juan Gea-Banacloche; Richard Childs; JOHN BENNETT
Hallucinations during voriconazole therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(1):e7-e10.
2008: Ben De Pauw; THOMAS WALSH; J Peter Donnelly; David A Stevens; John Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; JOHN BENNETT
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(12):1813-21.
2008: Dimitrios I Zonios; JOHN BENNETT
Update on azole antifungals.
Seminars in respiratory and critical care medicine 2008;29(2):198-210.
2008: JOHN BENNETT
Is real-time polymerase chain reaction ready for real use in detecting candidemia?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(6):897-8.
2007: Dimitrios I Zonios; Judith Falloon; Chiung-Yu Huang; Doreen G Chaitt; JOHN BENNETT
Cryptococcosis and idiopathic CD4 lymphocytopenia.
Medicine 2007;86(2):78-92.
2007: Reginald E Greene; Haran T Schlamm; Jörg Oestmann; Paul Stark; Christine Durand; Olivier Lortholary; John R Wingard; Raoul Herbrecht; Patricia Ribaud; Thomas Patterson; Peter Troke; David W Denning; JOHN BENNETT; Ben E de Pauw; Robert Rubin
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(3):373-9.
2007: Kuang-Hua Chen; Taiga Miyazaki; Huei-Fung Tsai; JOHN BENNETT
The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata.
Gene 2007;386(1-2):63-72.
2006: JOHN BENNETT
Echinocandins for candidemia in adults without neutropenia.
The New England journal of medicine 2006;355(11):1154-9.
2006: JOHN BENNETT
The debate: a case for randomized controls in invasive aspergillosis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2006;44 Suppl 1():S305-8.
2006: Taiga Miyazaki; Huei-Fung Tsai; JOHN BENNETT
Kre29p is a novel nuclear protein involved in DNA repair and mitotic fidelity in Candida glabrata.
Current genetics 2006;50(1):11-22.
2006: Wesley T Stevens; Charles D Bolan; Jaime M Oblitas; David F Stroncek; JOHN BENNETT; Susan F Leitman
Streptococcus agalactiae sepsis after transfusion of a plateletpheresis concentrate: benefit of donor evaluation.
Transfusion 2006;46(4):649-51.
2006: Huei-Fung Tsai; Anna A Krol; Kelly E Sarti; JOHN BENNETT
Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants.
Antimicrobial agents and chemotherapy 2006;50(4):1384-92.
2006: Taiga Miyazaki; Yoshitsugu Miyazaki; Koichi Izumikawa; Hiroshi Kakeya; Shunichi Miyakoshi; JOHN BENNETT; Shigeru Kohno
Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.
Antimicrobial agents and chemotherapy 2006;50(2):580-6.
2005: Thomas Patterson; Helen W Boucher; Raoul Herbrecht; David W Denning; Olivier Lortholary; Patricia Ribaud; Robert Rubin; John R Wingard; Ben DePauw; Haran T Schlamm; Peter Troke; JOHN BENNETT
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(10):1448-52.
2005: JOHN BENNETT
Salvage therapy for aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41 Suppl 6():S387-8.
2004: Huei-Fung Tsai; Martin Bard; Koichi Izumikawa; Anna A Krol; Aaron M Sturm; Nicholas T Culbertson; Charles A Pierson; JOHN BENNETT
Candida glabrata erg1 mutant with increased sensitivity to azoles and to low oxygen tension.
Antimicrobial agents and chemotherapy 2004;48(7):2483-9.
2004: JOHN BENNETT; Koichi Izumikawa; Kieren Marr
Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.
Antimicrobial agents and chemotherapy 2004;48(5):1773-7.
2003: Karoll J Cortez; Steven H Fischer; Gary A Fahle; Leslie B Calhoun; Richard W Childs; A John Barrett; JOHN BENNETT
Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients.
The Journal of infectious diseases 2003;188(7):967-72.
2003: Karoll J Cortez; THOMAS WALSH; JOHN BENNETT
Successful treatment of coccidioidal meningitis with voriconazole.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(12):1619-22.
2003: JOHN BENNETT; Carol A Kauffman; THOMAS WALSH; Ben E de Pauw; William E Dismukes; John N Galgiani; Michel Glauser; Raoul Herbrecht; Jeannette Lee; Peter Pappas; John Powers; John Rex; Paul Verweij; Claudio Viscoli
Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(Suppl 3):S123-7.
2003: JOHN BENNETT; John Powers; THOMAS WALSH; Claudio Viscoli; Ben E de Pauw; William E Dismukes; John N Galgiani; Michel Glauser; Raoul Herbrecht; Carol A Kauffman; Jeannette Lee; Peter Pappas; John Rex; Paul Verweij
Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(Suppl 3):S117-22.
2003: JOHN BENNETT; John Powers; Ben E de Pauw; William E Dismukes; John N Galgiani; Michel Glauser; Raoul Herbrecht; Carol A Kauffman; Jeannette Lee; Peter Pappas; John Rex; Paul Verweij; Claudio Viscoli; THOMAS WALSH
Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(Suppl 3):S113-6.
2003: Koichi Izumikawa; Hiroshi Kakeya; Huei-Fung Tsai; Brian Grimberg; JOHN BENNETT
Function of Candida glabrata ABC transporter gene, PDH1.
Yeast (Chichester, England) 2003;20(3):249-61.
2002: Luis Ostrosky-Zeichner; John H Rex; JOHN BENNETT; Bart Jan Kullberg
Deeply invasive candidiasis.
Infectious disease clinics of North America 2002;16(4):821-35.
2002: Karoll J Cortez; Brian Murphy; K N Almeida; J Beeler; R A Levandowski; Vee J Gill; R W Childs; A John Barrett; M Smolskis; JOHN BENNETT
Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation.
The Journal of infectious diseases 2002;186(6):834-8.
2002: Raoul Herbrecht; David W Denning; Thomas Patterson; JOHN BENNETT; Reginald E Greene; Jörg Oestmann; Winfried V Kern; Kieren Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter Troke; Ben de Pauw
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
The New England journal of medicine 2002;347(6):408-15.
2002: Justina Y Ju; Cynthia Polhamus; Kieren Marr; Steven M Holland; JOHN BENNETT
Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
Antimicrobial agents and chemotherapy 2002;46(5):1240-5.
2002: S Ascioglu; John H Rex; Ben E de Pauw; JOHN BENNETT; J Bille; F Crokaert; David W Denning; J Peter Donnelly; John Edwards; Z Erjavec; D Fiere; Olivier Lortholary; Johan Maertens; Jacques Meis; Thomas Patterson; J Ritter; Dominik Selleslag; P M Shah; D A Stevens; THOMAS WALSH
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(1):7-14.
2001: Karoll J Cortez; Dean D Erdman; Teresa C T Peret; Vee J Gill; R Childs; A John Barrett; JOHN BENNETT
Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population.
The Journal of infectious diseases 2001;184(9):1093-7.
2001: John H Rex; THOMAS WALSH; Mary D Nettleman; Elias J Anaissie; JOHN BENNETT; E J Bow; A J Carillo-Munoz; Pascal Chavanet; Gretchen A Cloud; D W Denning; B E de Pauw; J E Edwards Jr; John W Hiemenz; Carol A Kauffman; G Lopez-Berestein; P Martino; Jack D Sobel; David A Stevens; R Sylvester; J Tollemar; C Viscoli; M A Viviani; T Wu
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(1):95-106.
2001: Christopher J Graber; K N de Almeider; Richard Childs; A John Barrett; Vee J Gill; JOHN BENNETT
CMV reactivation in nonmyeloablative HSCT.
Bone marrow transplantation 2001;27(7):775.
2001: Christopher J Graber; K N de Almeida; Jane C Atkinson; D Javaheri; C D Fukuda; Vee J Gill; A John Barrett; JOHN BENNETT
Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Bone marrow transplantation 2001;27(5):537-42.
2000: DR Hospenthal; JOHN BENNETT
Persistence of cryptococcomas on neuroimaging.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1303-6.
2000: JOHN BENNETT
Editorial response: choosing amphotericin B formulations-between a rock and a hard place.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1164-5.
2000: Hiroshi Kakeya; Y Miyazaki; H Miyazaki; K Nyswaner; Brian Grimberg; JOHN BENNETT
Genetic analysis of azole resistance in the Darlington strain of Candida albicans.
Antimicrobial agents and chemotherapy 2000;44(11):2985-90.
2000: D A Stevens; V L Kan; Marc A Judson; V A Morrison; S Dummer; D W Denning; JOHN BENNETT; THOMAS WALSH; Thomas Patterson; G A Pankey
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(4):696-709.
2000: Iris Nora Tiraboschi; JOHN BENNETT; Carol A Kauffman; J H Rex; Corrado Girmenia; Jack D Sobel; Francesco Menichetti
Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2000;38 Suppl 1():199-204.
1999: Y Miyazaki; A Geber; H Miyazaki; Derek Falconer; T Parkinson; Christopher A Hitchcock; Brian Grimberg; K Nyswaner; JOHN BENNETT
Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans.
Gene 1999;236(1):43-51.
1999: David C Lamb; S Maspahy; Diane E Kelly; Nigel J Manning; A Geber; JOHN BENNETT; Steven L Kelly
Purification, reconstitution, and inhibition of cytochrome P-450 sterol delta22-desaturase from the pathogenic fungus Candida glabrata.
Antimicrobial agents and chemotherapy 1999;43(7):1725-8.
1999: M K Park; DR Hospenthal; JOHN BENNETT
Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(3):629-33.
1998: DR Hospenthal; JOHN BENNETT
Flucytosine monotherapy for cryptococcosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(2):260-4.
1998: H Miyazaki; Y Miyazaki; A Geber; T Parkinson; Christopher A Hitchcock; Derek Falconer; D J Ward; K Marsden; JOHN BENNETT
Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata.
Antimicrobial agents and chemotherapy 1998;42(7):1695-701.
1998: DR Hospenthal; Kyung J Kwon-Chung; JOHN BENNETT
Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(3):165-8.
1998: Arvind A Padhye; JOHN BENNETT; Michael R McGinnis; L Sigler; A Fliss; Ira Salkin
Biosafety considerations in handling medically important fungi.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36 Suppl 1():258-65.
1996: D J Krogstad; R D Pearson; JOHN BENNETT; R Dolin; G L Mandell
Dosage for malaria treatment.
Lancet 1996;348(9037):1311; author reply 1311-2.
1996: S D Salas; JOHN BENNETT; K J Kwon-Chung; J R Perfect; Peter R Williamson
Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans.
The Journal of experimental medicine 1996;184(2):377-86.
1996: V L Kan; A Geber; JOHN BENNETT
Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion.
Antimicrobial agents and chemotherapy 1996;40(7):1717-9.
1995: A Geber; Christopher A Hitchcock; J E Swartz; frank pullen; K E Marsden; K J Kwon-Chung; JOHN BENNETT
Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility.
Antimicrobial agents and chemotherapy 1995;39(12):2708-17.
1995: John H Rex; JOHN BENNETT; A M Sugar; P G Pappas; Jonathan S Serody; John Edwards; R G Washburn
Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(4):994-6.
1995: P Zhou; M C Sieve; JOHN BENNETT; K J Kwon-Chung; R P Tewari; R T Gazzinelli; A Sher; Robert A Seder
IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(2):785-95.
1995: A Varma; D Swinne; F Staib; JOHN BENNETT; K J Kwon-Chung
Diversity of DNA fingerprints in Cryptococcus neoformans.
Journal of clinical microbiology 1995;33(7):1807-14.
1994: John H Rex; JOHN BENNETT; A M Sugar; P G Pappas; Charles van der Horst; John Edwards; R G Washburn; W M Scheld; A W Karchmer; A P Dine
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
The New England journal of medicine 1994;331(20):1325-30.
1994: JOHN BENNETT
Fungi as a cause of otitis.
JAMA : the journal of the American Medical Association 1994;271(20):1628.
1994: Bruno Maresca; JOHN BENNETT; W Fonzi; C A Hitchcock; Jennifer lodge; Peter R Williamson
Molecular approaches to identify novel targets for future development of antifungal agents.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1994;32 Suppl 1():287-98.
1993: J H Rex; R A Larsen; William E Dismukes; G A Cloud; JOHN BENNETT
Catastrophic visual loss due to Cryptococcus neoformans meningitis.
Medicine 1993;72(4):207-24.
1993: Peter R Williamson; M A Huber; JOHN BENNETT
Role of maltase in the utilization of sucrose by Candida albicans.
The Biochemical journal 1993;291 ( Pt 3)():765-71.
1992: A Geber; Peter R Williamson; J H Rex; E C Sweeney; JOHN BENNETT
Cloning and characterization of a Candida albicans maltase gene involved in sucrose utilization.
Journal of bacteriology 1992;174(21):6992-6.
1992: A Geber; D E Higgins; A P Waters; JOHN BENNETT; T F McCutchan
Small subunit ribosomal RNA of Blastomyces dermatitidis: sequence and phylogenetic analysis.
Journal of general microbiology 1992;138(2):395-9.
1992: Kyung J Kwon-Chung; A Varma; Jennifer C Edman; JOHN BENNETT
Selection of ura5 and ura3 mutants from the two varieties of Cryptococcus neoformans on 5-fluoroorotic acid medium.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30(1):61-9.
1991: S J Devi; Rachel Schneerson; W Egan; T J Ulrich; D Bryla; John B Robbins; JOHN BENNETT
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.
Infection and immunity 1991;59(10):3700-7.
1991: V L Kan; JOHN BENNETT; M A Amantea; M C Smolskis; E McManus; D M Grasela; J W Sherman
Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers.
The Journal of infectious diseases 1991;164(2):418-21.
1991: V L Kan; JOHN BENNETT
Beta 1,4-oligoglucosides inhibit the binding of Aspergillus fumigatus conidia to human monocytes.
The Journal of infectious diseases 1991;163(5):1154-6.
1991: J H Rex; L H Hanson; M A Amantea; D A Stevens; JOHN BENNETT
Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography.
Antimicrobial agents and chemotherapy 1991;35(5):846-50.
1991: R G Washburn; B J Bryant-Varela; N C Julian; JOHN BENNETT
Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces.
Molecular immunology 1991;28(4-5):465-70.
1991: J H Rex; JOHN BENNETT; John Gallin; Harry L Malech; E S DeCarlo; D A Melnick
In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.
The Journal of infectious diseases 1991;163(4):849-52.
1990: JOHN BENNETT
Searching for the yeast connection.
The New England journal of medicine 1990;323(25):1766-7.
1990: JOHN BENNETT; M H Kroll; R G Washburn
Flucytosine interference in creatinine assay.
The Journal of infectious diseases 1990;162(2):571-2.
1990: J H Rex; JOHN BENNETT; John Gallin; Harry L Malech; D A Melnick
Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae.
The Journal of infectious diseases 1990;162(2):523-8.
1990: M R Evans; D K Henderson; JOHN BENNETT
Potential for laboratory exposures to biohazardous agents found in blood.
American journal of public health 1990;80(4):423-7.
1990: H C Neu; JOHN BENNETT; G P Bodey; R H Rubin; J J Schentag; A M Sugar
P&T Committee review of fluconazole: an effective alternative to antifungal therapy.
Hospital formulary 1990;25 Suppl B():9-14.
1990: J H Rex; JOHN BENNETT
Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1990;28(3):185-9.
1989: C L Alter; P H Levine; JOHN BENNETT; C Kessler; M Rick; R G Washburn; John Gallin; R W Miller; A D Auerbach
Dominantly transmitted hematologic dysfunction clinically similar to Fanconi's anemia.
American journal of hematology 1989;32(4):241-7.
1989: R G Washburn; JOHN BENNETT
Reversal of adrenal glucocorticoid dysfunction in a patient with disseminated histoplasmosis.
Annals of internal medicine 1989;110(1):86-7.
1988: V L Kan; JOHN BENNETT
Efficacies of four antifungal agents in experimental murine sporotrichosis.
Antimicrobial agents and chemotherapy 1988;32(11):1619-23.
1988: V L Kan; JOHN BENNETT
Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia.
The Journal of infectious diseases 1988;158(2):407-14.
1988: R G Washburn; D W Kennedy; M G Begley; D K Henderson; JOHN BENNETT
Chronic fungal sinusitis in apparently normal hosts.
Medicine 1988;67(4):231-47.
1988: C M Huang; M H Kroll; M Ruddel; R G Washburn; JOHN BENNETT
An enzymatic method for 5-fluorocytosine.
Clinical chemistry 1988;34(1):59-62.
1987: R G Washburn; John Gallin; JOHN BENNETT
Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways.
Infection and immunity 1987;55(9):2088-92.
1987: K J Kwon-Chung; Brian L Wickes; J L Booth; Helen Vishniac; JOHN BENNETT
Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans.
Infection and immunity 1987;55(8):1751-4.
1987: JOHN BENNETT; M M Friedman; B Dupont
Receptor-mediated clearance of Aspergillus galactomannan.
The Journal of infectious diseases 1987;155(5):1005-10.
1987: JOHN BENNETT
Rapid diagnosis of candidiasis and aspergillosis.
Reviews of infectious diseases 1987;9(2):398-402.
1987: B Dupont; M Huber; S J Kim; JOHN BENNETT
Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits.
The Journal of infectious diseases 1987;155(1):1-11.
1986: R G Washburn; C H Hammer; JOHN BENNETT
Inhibition of complement by culture supernatants of Aspergillus fumigatus.
The Journal of infectious diseases 1986;154(6):944-51.
1986: V L Kan; D K Henderson; JOHN BENNETT
Bioassay for SF 86-327, a new antifungal agent.
Antimicrobial agents and chemotherapy 1986;30(4):628-9.
1986: D K Henderson; V L Kan; JOHN BENNETT
Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro.
Clinical and experimental immunology 1986;65(3):639-46.
1986: R G Washburn; JOHN BENNETT
Paracoccidioidomycosis case report: cure with amphotericin B and triple sulfa.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1986;24(3):235-7.
1986: R G Washburn; D M Klym; M H Kroll; JOHN BENNETT
Rapid enzymatic method for measurement of serum flucytosine levels.
The Journal of antimicrobial chemotherapy 1986;17(5):673-7.
1986: D L Calhoun; G D Roberts; John N Galgiani; JOHN BENNETT; D S Feingold; James Jorgensen; G S Kobayashi; S Shadomy
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.
Journal of clinical microbiology 1986;23(2):298-301.
1985: J W Bailey; E Sada; C Brass; JOHN BENNETT
Diagnosis of systemic candidiasis by latex agglutination for serum antigen.
Journal of clinical microbiology 1985;21(5):749-52.
1985: R G Washburn; C U Tuazon; JOHN BENNETT
Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome.
The Journal of infectious diseases 1985;151(3):565-6.
1985: JOHN BENNETT; A K Bhattacharjee; Cornelis P J Glaudemans
Galactofuranosyl groups are immunodominant in Aspergillus fumigatus galactomannan.
Molecular immunology 1985;22(3):251-4.
1984: A K Bhattacharjee; JOHN BENNETT; Cornelis P J Glaudemans
Capsular polysaccharides of Cryptococcus neoformans.
Reviews of infectious diseases 1984;6(5):619-24.
1984: K J Kwon-Chung; JOHN BENNETT
Epidemiologic differences between the two varieties of Cryptococcus neoformans.
American journal of epidemiology 1984;120(1):123-30.
1984: D H Jacobs; A M Macher; R Handler; JOHN BENNETT; M J Collen; John Gallin
Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome.
Gastroenterology 1984;87(1):201-3.
1984: K J Kwon-Chung; JOHN BENNETT
High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions.
Zentralblatt für Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1984;257(2):213-8.
1984: JOHN BENNETT
Assessing response to therapy for mucosal candidiasis.
The Journal of infectious diseases 1984;149(2):284-5.
1983: R L Stiller; JOHN BENNETT; H J Scholer; M Wall; A Polak; D A Stevens
Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model.
The Journal of infectious diseases 1983;147(6):1070-7.
1983: A K Bhattacharjee; JOHN BENNETT; D R Bundle; Cornelis P J Glaudemans
Anticryptococcal type D antibodies raised in rabbits.
Molecular immunology 1983;20(4):351-9.
1983: JOHN BENNETT
Antigen detection in body fluids of patients with bacterial and fungal infections.
Transactions of the American Clinical and Climatological Association 1983;94():22-6.
1982: R L Stiller; JOHN BENNETT; H J Scholer; M Wall; A Polak; D A Stevens
Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.
Antimicrobial agents and chemotherapy 1982;22(3):482-7.
1982: D K Henderson; JOHN BENNETT; M A Huber
Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis.
The Journal of clinical investigation 1982;69(5):1185-90.
1982: K J Kwon-Chung; I Polacheck; JOHN BENNETT
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).
Journal of clinical microbiology 1982;15(3):535-7.
1982: K J Kwon-Chung; JOHN BENNETT; J C Rhodes
Taxonomic studies on Filobasidiella species and their anamorphs.
Antonie van Leeuwenhoek 1982;48(1):25-38.
1981: JOHN BENNETT; J S Remington
Miconazole in cryptococcosis and systemic candidiasis: a word of caution.
Annals of internal medicine 1981;94(5):708-9.
1981: JOHN BENNETT
Cryptococcal skin test antigen: preparation variables and characterization.
Infection and immunity 1981;32(1):373-80.
1981: K J Kwon-Chung; W B Hill; JOHN BENNETT
New, special stain for histopathological diagnosis of cryptococcosis.
Journal of clinical microbiology 1981;13(2):383-7.
1980: W E Dismukes; JOHN BENNETT; D J Drutz; John Graybill; J S Remington; D A Stevens
Criteria for evaluation of therapeutic response to antifungal drugs.
Reviews of infectious diseases 1980;2(4):535-45.
1980: JOHN BENNETT
Cryptococcosis.
The Western journal of medicine 1980;132(2):150.
1979: JOHN BENNETT; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis.
The New England journal of medicine 1979;301(3):126-31.
1979: E Segal; R A Berg; P A Pizzo; JOHN BENNETT
Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique.
Journal of clinical microbiology 1979;10(1):116-8.
1979: L Feldman; M Lamson; J F Gallelli; JOHN BENNETT
Surveillance of nosocomial infections by antibiotic monitoring.
JAMA : the journal of the American Medical Association 1979;241(26):2806-7.
1978: R B Diasio; D E Lakings; JOHN BENNETT
Evidence for conversion of 5-fluorocytosine to 5-fluorouracil in humans: possible factor in 5-fluorocytosine clinical toxicity.
Antimicrobial agents and chemotherapy 1978;14(6):903-8.
1978: K J Kwon-Chung; JOHN BENNETT
Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates.
American journal of epidemiology 1978;108(4):337-40.
1978: JOHN BENNETT; K J Kwon-Chung; T S Theodore
Biochemical differences between serotypes of Cryptococcus neoformans.
Sabouraudia 1978;16(3):167-74.
1978: R R MacGregor; JOHN BENNETT; A J Erslev
Erythropoietin concentration in amphotericin B-induced anemia.
Antimicrobial agents and chemotherapy 1978;14(2):270-3.
1978: A M Macher; JOHN BENNETT; J E Gadek; M M Frank
Complement depletion in cryptococcal sepsis.
Journal of immunology (Baltimore, Md. : 1950) 1978;120(5):1686-90.
1978: JOHN BENNETT; A E Jennings
Factors influencing susceptibility of Nocardia species to trimethoprim-sulfamethoxazole.
Antimicrobial agents and chemotherapy 1978;13(4):624-7.
1978: R B Diasio; JOHN BENNETT; C E Myers
Mode of action of 5-fluorocytosine.
Biochemical pharmacology 1978;27(5):703-7.
1978: A J Atkinson; JOHN BENNETT
Amphotericin B pharmacokinetics in humans.
Antimicrobial agents and chemotherapy 1978;13(2):271-6.
1978: JOHN BENNETT
Diagnosis and management of candidiasis in the immunosuppressed host.
Scandinavian journal of infectious diseases. Supplementum 1978;(16):83-6.
1977: JOHN BENNETT; K J Kwon-Chung; D H Howard
Epidemiologic differences among serotypes of Cryptococcus neoformans.
American journal of epidemiology 1977;105(6):582-6.
1976: R C Young; JOHN BENNETT; E W Chu
Organisms mimicking Pneumocystis carinii.
Lancet 1976;2(7994):1082-3.
1976: Joseph Aisner; Stephen C Schimpff; JOHN BENNETT; V M Young; P H Wiernik
Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital.
JAMA : the journal of the American Medical Association 1976;235(4):411-12.
1975: Stephen C Schimpff; JOHN BENNETT
Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection.
The Journal of allergy and clinical immunology 1975;55(6):430-41.
1974: JOHN BENNETT
Prevention of hospital-acquired systemic mycoses.
Preventive medicine 1974;3(4):515-6.
1974: R D Diamond; J E May; M A Kane; M M Frank; JOHN BENNETT
The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
Journal of immunology (Baltimore, Md. : 1950) 1974;112(6):2260-70.
1974: E R Block; JOHN BENNETT; L G Livoti; W J Klein; R R MacGregor; L Henderson
Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man.
Annals of internal medicine 1974;80(5):613-7.
1974: R C Young; JOHN BENNETT; G W Geelhoed; A S Levine
Fungemia with compromised host resistance. A study of 70 cases.
Annals of internal medicine 1974;80(5):605-12.
1974: JOHN BENNETT
Chemotherapy of systemic mycoses (second of two parts).
The New England journal of medicine 1974;290(6):320-3.
1974: R D Diamond; JOHN BENNETT
Prognostic factors in cryptococcal meningitis. A study in 111 cases.
Annals of internal medicine 1974;80(2):176-81.
1974: JOHN BENNETT
Chemotherapy of systemic mycoses (first of two parts).
The New England journal of medicine 1974;290(1):30-2.
1973: E R Block; JOHN BENNETT
Stability of amphotericin B in infusion bottles.
Antimicrobial agents and chemotherapy 1973;4(6):648-9.
1973: E R Block; A E Jennings; JOHN BENNETT
Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine.
Antimicrobial agents and chemotherapy 1973;4(4):392-5.
1973: R D Diamond; J E May; M Kane; M M Frank; JOHN BENNETT
The role of late complement components and the alternate complement pathway in experimental cryptococcosis.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1973;144(1):312-5.
1973: JOHN BENNETT
Diagnosis and therapy of systemic mycoses in the immunosuppressed host.
Transplantation proceedings 1973;5(3):1255-7.
1973: E R Block; A E Jennings; JOHN BENNETT
5-fluorocytosine resistance in Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 1973;3(6):649-56.
1973: R D Diamond; JOHN BENNETT
Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.
The Journal of infectious diseases 1973;127(6):694-7.
1973: R D Diamond; JOHN BENNETT
Disseminated Nocardia brasiliensis infection.
Archives of internal medicine 1973;131(5):735-6.
1973: JOHN BENNETT
The treatment of systemic mycoses.
Rational drug therapy 1973;7(4):1-4.
1973: JOHN BENNETT; H Bonner; A E Jennings; R I Lopez
Chronic meningitis caused by Cladosporium trichoides.
American journal of clinical pathology 1973;59(3):398-407.
1973: R D Diamond; JOHN BENNETT
Growth of Cryptococcus neoformans within human macrophages in vitro.
Infection and immunity 1973;7(2):231-6.
1973: E R Block; JOHN BENNETT
The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1973;142(2):476-80.
1973: R D Diamond; JOHN BENNETT
A subcutaneous reservoir for intrathecal therapy of fungal meningitis.
The New England journal of medicine 1973;288(4):186-8.
1973: E R Block; A E Jennings; JOHN BENNETT
Experimental therapy of cladosporiosis and sporotrichosis with 5-fluorocytosine.
Antimicrobial agents and chemotherapy 1973;3(1):95-8.
1972: A E Jennings; JOHN BENNETT
The isolation of red yeast-like fungi in a diagnostic laboratory.
Journal of medical microbiology 1972;5(4):391-4.
1972: R C Young; A Jennings; JOHN BENNETT
Species identification of invasive aspergillosis in man.
American journal of clinical pathology 1972;58(5):554-7.
1972: E R Block; JOHN BENNETT
Pharmacological studies with 5-fluorocytosine.
Antimicrobial agents and chemotherapy 1972;1(6):476-82.
1972: R D Diamond; R K Root; JOHN BENNETT
Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.
The Journal of infectious diseases 1972;125(4):367-76.
1971: R C Young; JOHN BENNETT
Invasive aspergillosis. Absence of detectable antibody response.
The American review of respiratory disease 1971;104(5):710-6.
1971: JOHN BENNETT; J W Bailey
Control for rheumatoid factor in the latex test for cryptococcosis.
American journal of clinical pathology 1971;56(3):360-5.
1971: C H Kirkpatrick; R R Rich; JOHN BENNETT
Chronic mucocutaneous candidiasis: model-building in cellular immunity.
Annals of internal medicine 1971;74(6):955-78.
1970: JOHN BENNETT
Clotrimazole: new drug for systemic mycoses?
Annals of internal medicine 1970;73(4):653-4.
1970: JOHN BENNETT
Clinical applications of serologic tests for systemic mycoses.
Modern treatment 1970;7(3):577-80.
1970: R C Young; JOHN BENNETT; Charles L Vogel; P P Carbone; V T DeVita
Aspergillosis. The spectrum of the disease in 98 patients.
Medicine 1970;49(2):147-73.
1969: D D Bindschadler; JOHN BENNETT
A pharmacologic guide to the clinical use of amphotericin B.
The Journal of infectious diseases 1969;120(4):427-36.
1969: D C Bird; J N Sheagren; JOHN BENNETT
Reticuloendothelial phagocytic function during systemic mycotic infections in man.
The Journal of laboratory and clinical medicine 1969;74(2):340-5.
1969: JOHN BENNETT; W R Piggott; J P Utz; C W Emmons
Assay of antifungal agent saramycetin (X-5079C) in patient body fluids.
The American review of respiratory disease 1969;99(6):964-5.
1968: B Tynes; K N Mason; A E Jennings; JOHN BENNETT
Variant forms of pulmonary cryptococcosis.
Annals of internal medicine 1968;69(6):1117-25.
1968: A Jennings; JOHN BENNETT; V Young
Identification of Cryptococcus neoformans in a routine clinical laboratory.
Mycopathologia et mycologia applicata 1968;35(3):256-64.
1968: D D Bindschadler; JOHN BENNETT
Serology of human cryptococcosis.
Annals of internal medicine 1968;69(1):45-52.
1968: A J Atkinson; JOHN BENNETT
Experience with a new skin test antigen prepared from Cryptococcus neoformans.
The American review of respiratory disease 1968;97(4):637-43.
1968: D E Wilson; JOHN BENNETT; J W Bailey
Serologic grouping of Cryptococcus neoformans.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1968;127(3):820-3.
1967: D E Wilson; J J Mann; JOHN BENNETT; J P Utz
Clinical features of extracutaneous sporotrichosis.
Medicine 1967;46(3):265-79.
1967: W Richard Green; JOHN BENNETT
Coccidioidomycosis. Report of a case with clinical evidence of ocular involvement.
Archives of ophthalmology 1967;77(3):337-40.
1966: D E Wilson; T W Williams; JOHN BENNETT
Further experience with the alcohol test for cryptococcal meningitis.
The American journal of the medical sciences 1966;252(5):532-6.
1966: JOHN BENNETT
Susceptibility of Cryptococcus neoformans to amphotericin B.
Antimicrobial agents and chemotherapy 1966;6():405-10.
1965: JOHN BENNETT; H F HASENCLEVER
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.
Journal of immunology (Baltimore, Md. : 1950) 1965;94():916-20.
1965: W Richard Green; JOHN BENNETT; R D GOOS
OCULAR PENETRATION OF AMPHOTERICIN B: A REPORT OF LABORATORY STUDIES AND A CASE REPORT OF POSTSURGICAL CEPHALOSPORIUM ENDOPHTHALMITIS.
Archives of ophthalmology 1965;73():769-75.
1965: JOHN BENNETT; H F HASENCLEVER; G L BAUM
EVALUATION OF A SKIN TEST FOR CRYPTOCOCCOSIS.
The American review of respiratory disease 1965;91():616.
1964: JOHN BENNETT; T W WILLIAMS; W PIGGOTT; C W EMMONS
IN VIVO ACTIVITY OF COLLOIDAL HAMYCIN, AN ANTIFUNGAL ANTIBOTIC.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1964;117():166-70.
1964: W T BUTLER; JOHN BENNETT; G J HILL
ELECTROCARDIOGRAPHIC AND ELECTROLYTE ABNORMALITIES CAUSED BY AMPHOTERICIN B IN DOG AND MAN.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1964;116():857-63.
1964: JOHN BENNETT
AMPHOTERICIN B TOXICITY; REVIEW OF SELECTED ASPECTS OF PHARMACOLOGY.
Annals of internal medicine 1964;61():335-40.
1964: W T BUTLER; JOHN BENNETT; D W ALLING; P T WERTLAKE; J P UTZ; G J HILL
NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS.
Annals of internal medicine 1964;61():175-87.
1964: R H WILKINS; JOHN BENNETT; P T WERTLAKE; J T WEST
MESENCHYMOMA AND VISCERAL CRYPTOCOCCOSIS. REPORT OF A CASE.
Archives of surgery (Chicago, Ill. : 1960) 1964;88():761-7.
1964: JOHN BENNETT; H F HASENCLEVER; B S TYNES
DETECTION OF CRYPTOCOCCAL POLYSACCHARIDE IN SERUM AND SPINAL FLUID: VALUE IN DIAGNOSIS AND PROGNOSIS.
Transactions of the Association of American Physicians 1964;77():145-50.
1963: JOHN BENNETT; G J HILL; W T BUTLER; C W EMMONS
CORRELATION OF PARTICLE SIZE OF INTRAVENOUS AMPHOTERICIN B WITH TOXIC AND CHEMOTHERAPEUTIC EFFECTS.
Antimicrobial agents and chemotherapy 1963;161():745-52.